Molecular and Genomic Laboratory Testing

The contract seeks a subcontractor to conduct advanced molecular and genomic testing on tissue samples from individuals with neurofibromatosis, specifically focusing on next-generation sequencing, RNA sequencing, and other related molecular profiling techniques. The work aims to generate detailed genetic and transcriptomic data to enhance understanding of the disease’s molecular mechanisms, with the expectation that results will support clinical or research initiatives tied to defense health programs. All testing must adhere to high standards of accuracy, reproducibility, and data integrity, with samples received from designated sources and processed under protocols that ensure traceability and quality control. The opportunity is posted under NAICS code 541380, indicating it is classified as other scientific and technical consulting services, and is issued by the Defense Health Agency Contracting Activity under the Department of Defense. Interested parties must submit proposals by the deadline of September 22, 2026, and the work is expected to be performed domestically though the exact location is not specified. The contract does not include set-aside provisions for small businesses or other designated categories, and there is no designated point of contact listed in the posting. Proposals should demonstrate technical expertise in genomic analysis, experience with clinical or research-grade tissue samples, and the capacity to deliver actionable data within stringent timelines.